Ajanta Pharma Limited
AJANTPHARM
Kedudukan dalam Saham
#3706
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Harga Saham
$36.41
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$4.55B
Perubahan (1 hari)
-0.54%
Perubahan (1 tahun)
31.32%
Negara
IN
Perdagangan Ajanta Pharma Limited (AJANTPHARM)
Kategori
Healthcare
Pendapatan untuk Ajanta Pharma Limited (AJANTPHARM)
Pendapatan pada Jun 2026 TTM: $164.80M
Menurut laporan kewangan terkini Ajanta Pharma Limited, pendapatan semasa syarikat ialah $164.80M. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $133.59M, peningkatan berbanding pendapatan pada tahun 2023 yang berjumlah $90.68M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Ajanta Pharma Limited dari 2005 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $164.80M | 18.53% |
| 2025 | $139.04M | 4.08% |
| 2024 | $133.59M | 47.31% |
| 2023 | $90.68M | -24.31% |
| 2022 | $119.81M | -2.57% |
| 2021 | $122.97M | 39.52% |
| 2020 | $88.14M | 19.01% |
| 2019 | $74.06M | -22.54% |
| 2018 | $95.62M | -4.34% |
| 2017 | $99.95M | 20.97% |
| 2016 | $82.63M | 13.06% |
| 2015 | $73.08M | 32.80% |
| 2014 | $55.03M | 69.13% |
| 2013 | $32.54M | 81.39% |
| 2012 | $17.94M | 41.32% |
| 2011 | $12.69M | 47.07% |
| 2010 | $8.63M | 46.96% |
| 2009 | $5.87M | -18.63% |
| 2008 | $7.22M | 61.49% |
| 2007 | $4.47M | 39.66% |
| 2006 | $3.20M | 48.67% |
| 2005 | $2.15M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 970.72% |
IN
|
